'Love hormone' improves attachment issues in people with autism

(KU Leuven) Oxytocin, often dubbed the 'love hormone', is known to promote social bonding. Researchers at KU Leuven have now discovered that administering oxytocin to adult men with autism makes them more open to close emotional bonds with others. The hormone has positive long-term effects as well. The researchers published their findings in the journals Molecular Autism and Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news

Related Links:

BACKGROUND: There is increasing interest in the clinical and aetiological overlap between autism spectrum disorders and schizophrenia spectrum disorders, reported to co-occur at both diagnostic and trait levels. Individually, sub-clinical autistic and psyc...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Short sleep duration is a known risk factor for suicidality in the general population, yet it is unclear how short sleep interacts with autism traits in predicting suicidality. In this cross-sectional online study, a general population sample (N  = 650)...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
This study aimed to compare the severities of psychopathologies and the level of self-esteem among 219 adolescents with high-functioning autism spectrum disorder (ASD) who were classified into pure perpetrators, pure victims, perpetrator-victims, and neutr...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Several neurodevelopmental disorders (NDDs) including Developmental Dyslexia (DD), Autism Spectrum Disorder (ASD), but not Attention Deficit Hyperactive Disorder (ADHD), are reported to show deficits in global motion processing. Such behavioral deficits have been linked to a temporal processing deficiency. However, to date, there have been few studies assessing the temporal processing efficiency of the Magnocellular M pathways through temporal modulation. Hence, we measured achromatic flicker fusion thresholds at high and low contrast in nonselective samples of NDDs and neurotypicals (mean age 10, range 7–12 years, n...
Source: Frontiers in Human Neuroscience - Category: Neuroscience Source Type: research
Conclusion: PCDH19 is a major causative gene in patients with epilepsy and further data is required to gain a better understanding of phenotype-genotype correlation. In addition to gene sequencing, deletion/duplication analysis will improve the molecular diagnosis in patients with clinical findings.
Source: Annals of Indian Academy of Neurology - Category: Neurology Authors: Source Type: research
Conclusions: In terms of clinical implications, the heterogeneity of NF1 phenotypical manifestations needs to be considered when developing assessment and remediation approaches for children with complex NF1. PMID: 32089936 [PubMed]
Source: Case Reports in Psychiatry - Category: Psychiatry Tags: Case Rep Psychiatry Source Type: research
Condition:   Autism Spectrum Disorder Interventions:   Behavioral: JASPER;   Behavioral: jasPEER;   Behavioral: Structured Teaching Sponsors:   University of California, Los Angeles;   National Institutes of Health (NIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The National Institute of Mental Health (NIMH) Office of Autism Research Coordination (OARC) is pleased to invite you to attend our annual special event to recognize National Autism Awareness Month.For more information go tohttps://iacc.hhs.govAir date: 4/15/2020 6:00:00 PM
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
TUESDAY, Feb. 25, 2020 -- By the time he was 7 months old, John Michael Crawford had been diagnosed with a rare genetic disorder called tuberous sclerosis, associated with a high risk of developmental delays, including autism. Early intervention...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
In Reply Mr Ne ’eman and colleagues raise important points regarding the use of the CYBOCS-PDD in our study. Our trial aimed to investigate a biological concept and provide evidence as to whether fluoxetine could reduce obsessive-compulsive behaviors in children and adolescents with autism spectrum disorders. Cl inicians regularly use these medications, and a Cochrane review had called for proof of their efficacy. The aim was to extend the evidence base and ultimately improve the care of young people with autism spectrum disorders. The CYBOCS-PDD was chosen because of its use in previous studies and evidenc e in this...
Source: JAMA - Category: General Medicine Source Type: research
More News: Autism | Brain | Hormones | International Medicine & Public Health | Molecular Biology | Neurology | Neuroscience | Psychiatry | Science